Can GPCR, such as Kappa Opioid Receptor, be a Viable Therapeutic Target for Reducing or Preventing Neuroinflammation?

@article{Park2014CanGS,
  title={Can GPCR, such as Kappa Opioid Receptor, be a Viable Therapeutic Target for Reducing or Preventing Neuroinflammation?},
  author={S. Park and Li-Na Wei},
  journal={Clinical and Experimental Pharmacology},
  year={2014},
  volume={4}
}
Copyright: © 2014 Park SW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. G protein-coupled receptors (GPCRs) are 7-transmembrane domain containing proteins that mediate a wide range of biological processes and are the most favored drug targets. Approximately 40% of modern drugs are designed to target… Expand

References

SHOWING 1-5 OF 5 REFERENCES
Therapeutic potential of β-arrestin- and G protein-biased agonists.
  • 415
Microglial Dysregulation in Psychiatric Disease
  • 195
  • PDF
Cell Death and Differentiation
  • 2013